AMZN vs CUE · P/E 31, rev $200.61B vs rev $13.6M
Amazon.com Inc (AMZN) versus Cue Biopharma (CUE) — a side-by-side from cached financials, not a winner call.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andy Jassy.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Latest reported AMZN revenue for 2026-06-30 was $200.61B. Net income was $62.65B. Revenue was up 10.5% from 2026-03-31 to 2026-06-30. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Latest reported CUE revenue for 2026-06-30 was $13.6M. Net income was -$158.2M. CUE currently screens at market cap $59.5M.
AMZN currently screens at market cap $2.55T and trailing P/E 30.6. CUE currently screens at market cap $59.5M.
Not investment advice. Open the AMZN and CUE stock pages for the full models.
Not investment advice.